Literature DB >> 25813453

Comparing the Impact of Refractive and Nonrefractive Vision Loss on Functioning and Disability: The Salisbury Eye Evaluation.

Nazlee Zebardast1, Bonnielin K Swenor1, Suzanne W van Landingham1, Robert W Massof1, Beatriz Munoz1, Sheila K West1, Pradeep Y Ramulu2.   

Abstract

PURPOSE: To compare the effects of uncorrected refractive error (URE) and nonrefractive visual impairment (VI) on performance and disability measures.
DESIGN: Cross-sectional, population-based study. PARTICIPANTS: A total of 2469 individuals with binocular presenting visual acuity (PVA) of ≥ 20/80 who participated in the first round of the Salisbury Eye Evaluation study.
METHODS: The URE was defined as binocular PVA of ≤ 20/30, improving to >20/30 with subjective refraction. The VI was defined as post-refraction binocular best-corrected visual acuity (BCVA) of ≤ 20/30. The visual acuity decrement due to VI was calculated as the difference between BCVA and 20/30, whereas visual acuity due to URE was taken as the difference between PVA and BCVA. Multivariable regression analyses were used to assess the disability impact of (1) vision status (VI, URE, or normal vision) using the group with normal vision as reference and (2) a 1-line decrement in acuity due to VI or URE. MAIN OUTCOME MEASURES: Objective measures of visual function were obtained from timed performance of mobility and near vision tasks, self-reported driving cessation, and self-reported visual difficulty measured by the Activities of Daily Vision (ADV) scale. The ADV responses were analyzed using Rasch analysis to determine visual ability.
RESULTS: Compared with individuals with normal vision, subjects with VI (n = 191) had significantly poorer objective and subjective visual functioning in all metrics examined (P < 0.05), whereas subjects with URE (n = 132) demonstrated slower walking speeds, slower near task performance, more frequent driving cessation, and lower ADV scores (P < 0.05), but did not demonstrate slower stair climbing or descent speed. For all functional metrics evaluated, the impact of VI was greater than the impact of URE. The impact of a 1-line VA decrement due to VI was associated with greater deficits in mobility measures and driving cessation when compared with a 1-line VA decrement due to URE.
CONCLUSIONS: Visual impairment is associated with greater disability than URE across a wide variety of functional measures, even in analyses adjusting for the severity of vision loss. Refractive and nonrefractive vision loss should be distinguished in studies evaluating visual disability and be understood to have differing consequences.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25813453      PMCID: PMC4446156          DOI: 10.1016/j.ophtha.2015.02.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  39 in total

1.  Depression and anxiety in visually impaired older people.

Authors:  Jennifer R Evans; Astrid E Fletcher; Richard P L Wormald
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

2.  Treatment of uncorrected refractive error improves vision-specific quality of life.

Authors:  Anne L Coleman; Fei Yu; Emmett Keeler; Carol M Mangione
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

3.  Impact of severity and bilaterality of visual impairment on health-related quality of life.

Authors:  Rohit Varma; Joanne Wu; Kelly Chong; Stanley P Azen; Ron D Hays
Journal:  Ophthalmology       Date:  2006-08-04       Impact factor: 12.079

4.  Visual acuity and chart luminance.

Authors:  J E Sheedy; I L Bailey; T W Raasch
Journal:  Am J Optom Physiol Opt       Date:  1984-09

Review 5.  Global estimates of visual impairment: 2010.

Authors:  Donatella Pascolini; Silvio Paolo Mariotti
Journal:  Br J Ophthalmol       Date:  2011-12-01       Impact factor: 4.638

6.  How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation.

Authors:  Sheila K West; Gary S Rubin; Aimee T Broman; Beatriz Muñoz; Karen Bandeen-Roche; Kathleen Turano
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study.

Authors:  Ee-Munn Chia; Paul Mitchell; Elvis Ojaimi; Elena Rochtchina; Jie Jin Wang
Journal:  Ophthalmic Epidemiol       Date:  2006-12       Impact factor: 1.648

8.  Vision impairment, ocular conditions, and vision-specific function: the Singapore Malay Eye Study.

Authors:  Ecosse L Lamoureux; Elaine W Chong; Julian Thumboo; Hwee Lin Wee; Jie Jin Wang; Seang-Mei Saw; Tin Aung; Tien Y Wong
Journal:  Ophthalmology       Date:  2008-06-26       Impact factor: 12.079

9.  The impact of vision loss on postural stability and balance strategies in individuals with profound vision loss.

Authors:  Christopher T Ray; Michael Horvat; Ronald Croce; R Christopher Mason; Steven L Wolf
Journal:  Gait Posture       Date:  2007-11-26       Impact factor: 2.840

10.  The impact of corrected and uncorrected refractive error on visual functioning: the Singapore Malay Eye Study.

Authors:  Ecosse L Lamoureux; Seang-Mei Saw; Julian Thumboo; Hwee Lin Wee; Tin Aung; Paul Mitchell; Tien Y Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06       Impact factor: 4.799

View more
  13 in total

1.  Self-reported Vision Impairment and Subjective Well-being in Older Adults: A Longitudinal Mediation Analysis.

Authors:  Xiaoling Xiang; Vicki A Freedman; Khushali Shah; Rita X Hu; Brian C Stagg; Joshua R Ehrlich
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-02-14       Impact factor: 6.053

2.  Poor Vision and Self-Reported Functional Difficulties among Recently Hospitalized Individuals in the United States.

Authors:  Jeffrey Willis; Pradeep Y Ramulu
Journal:  Ophthalmic Epidemiol       Date:  2016-05-09       Impact factor: 1.648

3.  Association of Visual Acuity Improvement With Uncorrected Refractive Error in Patients New to Low Vision Clinics.

Authors:  Xinxing Guo; Bonnielin K Swenor; Judith E Goldstein
Journal:  JAMA Ophthalmol       Date:  2020-07-01       Impact factor: 7.389

4.  The prevalence and causes of pediatric uncorrected refractive error: Pooled data from population studies for Global Burden of Disease (GBD) sub-regions.

Authors:  He Cao; Xiang Cao; Zhi Cao; Lu Zhang; Yue Han; Changchun Guo
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

5.  Age-Related Imbalance Is Associated With Slower Walking Speed: An Analysis From the National Health and Nutrition Examination Survey.

Authors:  Yanjun J Xie; Elizabeth Y Liu; Eric R Anson; Yuri Agrawal
Journal:  J Geriatr Phys Ther       Date:  2017 Oct/Dec       Impact factor: 3.381

Review 6.  Physical activity, visual impairment, and eye disease.

Authors:  Sharon R Ong; Jonathan G Crowston; Paul D Loprinzi; Pradeep Y Ramulu
Journal:  Eye (Lond)       Date:  2018-04-03       Impact factor: 3.775

7.  Visual Impairment and Objectively Measured Physical Activity in Middle-Aged and Older Adults.

Authors:  Yurun Cai; Jennifer A Schrack; Hang Wang; Jian-Yu E; Amal A Wanigatunga; Yuri Agrawal; Jacek K Urbanek; Eleanor M Simonsick; Luigi Ferrucci; Bonnielin K Swenor
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-11-15       Impact factor: 6.053

Review 8.  Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review.

Authors:  Seyed-Farzad Mohammadi; Ghasem Saeedi-Anari; Elham Ashrafi; Seyed-Mehrdad Mohammadi; Farshad Farzadfar; Alireza Lashay; Hassan Hashemi
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep

Review 9.  Refractive error in underserved adults: causes and potential solutions.

Authors:  V Swetha E Jeganathan; Alan L Robin; Maria A Woodward
Journal:  Curr Opin Ophthalmol       Date:  2017-07       Impact factor: 3.761

Review 10.  The Treatment Paradigm for the Implantable Miniature Telescope.

Authors:  Vincent S Hau; Nikolas London; Michelle Dalton
Journal:  Ophthalmol Ther       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.